Development of a Blood Test for Marfan Syndrome
Status unconfirmed
Conditions studied: Marfan Syndrome, Marfan Related Disorders, Control Subjects
In brief
The objective of this study is to determine whether a simple blood test can be a useful clinical tool for monitoring aortic disease in Marfan syndrome and Marfan-related disorders.
Key facts
- Study ID
- NCT02148900
- Run by
- Shriners Hospitals for Children
- People needed
- 336
- Starts
- 2013-05-01
- Expected to finish
- 2017-12-01
- Last updated by the study team
- 2017-01-05
Who can join
Age: 4 and older, up to 26. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 4-26 years of age for all participants
- Diagnosis of Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, or Familial Thoracic Aortic Aneurysm and Dissection for inclusion in Marfan and Marfan-related disorders groups
- Diagnosis of unaffected by Marfan syndrome and Marfan-related disorders for inclusion in control group
- Able and willing to sign informed consent/assent
- Signed HIPPA compliant research authorization
You may not qualify if…
- Other known cardiovascular disorder for unaffected controls
Where it is running
- Lurie Childrens Hospital — Chicago, Illinois, United States (enrolling)
- University of Nebraska — Omaha, Nebraska, United States (enrolling)
- Oregon Health & Science University — Portland, Oregon, United States (enrolling)
- Shriners Hospital for Children — Portland, Oregon, United States (enrolling)
- University of Texas at Houston — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.